CatalystPit

MIRMMirum Pharmaceuticals, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $85.48 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$5.55B
RECENT INSIDER TRADES
  • 2026-10-06 · Peetz Christopher (CHIEF EXECUTIVE OFFICER) · OTHER
  • 2026-09-15 · BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) · SELL
  • 2026-09-15 · BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) · OTHER
  • 2026-09-03 · Howe Jolanda (SVP, GLOBAL CONTROLLER) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders348
Shares held91,259,727
Value$9.02B
Percent of shares outstanding140.55%
As of quarter end2026-06-30
RECENT NEWS
  • Mirum Pharmaceuticals to report Livmarli trial results Monday
  • Mirum Pharmaceuticals to share phase 3 LIVMARLI study results
  • Citizens raises Mirum Pharmaceuticals price target on HDV data
  • Mirum Pharmaceuticals, Inc. Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript
  • Stifel reiterates Mirum Pharmaceuticals stock rating on trial data
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Mirum Pharmaceuticals, Inc. (MIRM) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit